L4I Logo
  • Emerging Infections
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • GESI
  • LEARNING LIBRARY
  • Primary Healthcare

This section hosts guidelines, manuals and toolkits to strengthen public health practice.

Resources

FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Emerging Pandemics

Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy

07 Jul 2022

Women who are pregnant and have symptomatic coronavirus disease 2019 (Covid-19) are more likely than non-pregnant women to experience negative outcomes. Pregnant women have been advised to have the Covid-19 immunization in part as a result of these findings. However, compared to non-pregnant women, pregnant women's uptake has been lower. The barrier to maternity vaccination continues to be the safety concern of many women. This study, which involved pregnant women between the ages of 16 and 49, was retrospective, observational, and matched. This study compares the frequencies of 25 medically attended acute adverse events—including clinically significant outcomes and known reactogenic adverse events—among vaccinated women to matched unvaccinated controls. In subgroup analyses stratified by vaccination dose and mRNA vaccine manufacturer and comparing the incidence of outcomes in the two groups, relationships were comparable. A few of the study's limitations were the presence of wide confidence intervals around some rate ratios, the potential misclassification or incomplete capture of Covid-19 vaccine exposure or other covariates, and the potential underestimation of outcome incidence if the actual risk interval varied from the 21-day or 42-day interval used in this study. Acute adverse effects following the Covid-19 immunization that required medical attention soon before or during pregnancy were uncommon. The clinically significant acute adverse events that were assessed were not connected with higher risk after receiving the Covid-19 vaccination. The current data expand on the expanding body of research that supports the safety of receiving the Covid-19 vaccine while pregnant.

Download PDF
PUBLISHED BY
The New England Journal of Medicine
YEAR OF PUBLISHING
2022
AUTHORS
Allison Naleway et al

Categories

COVID-19
KEY ORGANIZATIONS

FOLLOW US

  • HOME
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
  • LEARNING LIBRARY
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2023 Swasti Health Catalyst

Get the latest!

Learning4impact provides a wealth of resources to support your public health work or research.

Sign up to get latest resources on public health!

Submit Feedback

Download Now

Yes, Subscribe me to the Learning4impact newsletter!
  • EMERGING INFECTIONS
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • LEARNING LIBRARY
  • Primary Healthcare